• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

Acumen rides aducanumab, amyloid and Alzheimer's waves on its IPO voyage

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 10, 2021 at 11:22: AM
via Acumen Pharmaceuticals is filing for a $100 million initial public offering hot on the heels of the FDA’s conditional approval of Biogen's controversial Alzheimer's disease drug Aduhelm (aducanumab).

article source
 






Top Bottom
Back
Quote